GlaxoSmithKline Plans to Launch Vaccines

GlaxoSmithKline Plans to Launch Five Major Vaccines Over Next Five Years Worth Up to $18 Billion

Our Hometown Pharmaceutical Company!!!...

link from yahoo finance AP story

Pharma's Cutting Edge - A Crownstone Publication

a review of the BIO 2005 event...from an investment viewpoint...

Pharma's Cutting Edge - A Crownstone Publication

Genentech buys Biogen Idec plant for $408m

link from in-pharma-tech

20/06/2005 - US biotechnology company Biogen Idec has said that it plans to sell a California manufacturing plant built to produce its withdrawn multiple sclerosis drug Tysabri (natalizumab) to Genentech, reports Phil Taylor.

Maybe the plant needs to be converted to produce the other product!!!

tryin' to catch up...

been screaming busy...

I'll be trying to catch up on the posting a bit...

Bristol-Myers Plans Waiting Period on New-Drug Ads

maybe this will end all of those adds where you don't know what the product is intended to treat...

link from Reuters

SARS Vaccine: Attack Of The Virus-Killer Tomatoes

Plants tweaked to produce SARS vaccine

link from Reuters

Scientists Grow Brain Cells In A Dish

"I'd unravel every riddle... for every individdle..."

C'mon everbody, sing along...

link from biospace

Pfizer to Acquire Vicuron for $1.9 Billion

Pfizer, Vicuron Pharmaceutical Companies Announce $1.9 Billion Merger Agreement

The Big get Bigger...


link from Yahoo Finance

Stem Cell Advocates Meet, Plan Strategy

in Texas, no less...

link from yahoo.com

Biotech's "Fantastic Future Ahead"

Some bold predictions on what's coming for the industry from Ernst & Young's Scott Morrison

On June 1, financial-services provider Ernst & Young released its 19th annual report on the biotechnology industry. The firm is so optimistic about biotech's future it declares that in the U.S., the sector is "coming of age."

link from business week online

hey, you didn't hear this from me...

Researchers make antibodies in egg whites

04/06/2005 - Scientists have successfully achieved the production of a functional humanised antibody in the whites of eggs laid by a transgenic hen, opening the door to using transgenic flocks as an alternative to mammalian cell culture for the production of many protein drugs, reports Phil Taylor.

link from in-pharma tech

Maybe firms will start building a collection of facilties to house flocks of poultry...

People on the move- at Merck

from in-pharma-tech

04/06/2005 - In-PharmaTechnologist.com reports its periodic round-up of new appointments in the pharmaceutical sector, headlined this week by the appointment of a new head of manufacturing at US drugmaker Merck & Co.

Willie Deese, currently senior vice president of global procurement at Merck & Co, has been named president of the group's manufacturing division, succeeding Richard Clark who has been elected chief executive of the firm following the recently announced resignation of Raymond Gilmartin.

Biotech's Hype And Hope Yielded Losses

several articles regarding new report from Ernst and Young regarding the biotechnology sector...

[Update]: link from chicago tribune

link from boston globe.com

link from sfgate.com

FDA Accelerated Drug Approval System Flawed

Speedy drug-review process 'broken'

Markey seeks fines for firms that don't complete studies

story link from boston globe